Trifluperidol

{{Drugbox | Verifiedfields = changed | verifiedrevid = 470614624 | IUPAC_name = 1-(4-fluorophenyl)- 4-{4-hydroxy- 4-[3-(trifluoromethyl)phenyl] piperidin-1-yl} butan-1-one | image = Trifluperidol.png | width = 200

| tradename = | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US = | legal_status = | routes_of_administration = Oral

| bioavailability = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref =  ^N | CAS_number = 749-13-3 | ATC_prefix = N05 | ATC_suffix = AD02 | ATC_supplemental = | PubChem = 5567 | DrugBank_Ref =  ^Y | DrugBank = | ChemSpiderID_Ref =  ^Y | ChemSpiderID = 5366 | UNII_Ref =  ^Y | UNII = R8869Q7R8I | ChEMBL_Ref =  ^Y | ChEMBL = 15023

| C=22 | H=23 | F=4 | N=1 | O=2 | molecular_weight = 409.417 g/mol | smiles = FC(F)(F)c1cccc(c1)C3(O)CCN(CCCC(=O)c2ccc(F)cc2)CC3 | InChI = 1/C22H23F4NO2/c23-19-8-6-16(7-9-19)20(28)5-2-12-27-13-10-21(29,11-14-27)17-3-1-4-18(15-17)22(24,25)26/h1,3-4,6-9,15,29H,2,5,10-14H2 | InChIKey = GPMXUUPHFNMNDH-UHFFFAOYAW | StdInChI_Ref =  ^Y | StdInChI = 1S/C22H23F4NO2/c23-19-8-6-16(7-9-19)20(28)5-2-12-27-13-10-21(29,11-14-27)17-3-1-4-18(15-17)22(24,25)26/h1,3-4,6-9,15,29H,2,5,10-14H2 | StdInChIKey_Ref =  ^Y | StdInChIKey = GPMXUUPHFNMNDH-UHFFFAOYSA-N }}

WikiDoc Resources for Trifluperidol
Articles
Most recent articles on Trifluperidol Most cited articles on Trifluperidol Review articles on Trifluperidol Articles on Trifluperidol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Trifluperidol Images of Trifluperidol Photos of Trifluperidol Podcasts & MP3s on Trifluperidol Videos on Trifluperidol
Evidence Based Medicine
Cochrane Collaboration on Trifluperidol Bandolier on Trifluperidol TRIP on Trifluperidol
Clinical Trials
Ongoing Trials on Trifluperidol at Clinical Trials.gov Trial results on Trifluperidol Clinical Trials on Trifluperidol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Trifluperidol NICE Guidance on Trifluperidol NHS PRODIGY Guidance FDA on Trifluperidol CDC on Trifluperidol
Books
Books on Trifluperidol
News
Trifluperidol in the news Be alerted to news on Trifluperidol News trends on Trifluperidol
Commentary
Blogs on Trifluperidol
Definitions
Definitions of Trifluperidol
Patient Resources / Community
Patient resources on Trifluperidol Discussion groups on Trifluperidol Patient Handouts on Trifluperidol Directions to Hospitals Treating Trifluperidol Risk calculators and risk factors for Trifluperidol
Healthcare Provider Resources
Symptoms of Trifluperidol Causes & Risk Factors for Trifluperidol Diagnostic studies for Trifluperidol Treatment of Trifluperidol
Continuing Medical Education (CME)
CME Programs on Trifluperidol
International
Trifluperidol en Espanol Trifluperidol en Francais
Business
Trifluperidol in the Marketplace Patents on Trifluperidol
Experimental / Informatics
List of terms related to Trifluperidol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Trifluperidol is a typical antipsychotic of the butyrophenone chemical class. It has general properties similar to those of haloperidol, but is considerably more potent by weight, and causes relatively more severe side effects, especially tardive dyskinesia and other extrapyramidal effects. It is used in the treatment of psychoses including mania and schizophrenia. It was discovered at Janssen Pharmaceutica in 1959.

Synthesis

Trifluperidol Synthesis: P. Janssen, J. Adriaan, GB 895309  (1962), Template:US Patent (1969).

References

• Gallant DM, Bishop MP, Timmons E, Steele CA, A controlled evaluation of Trifluperidol: a new potent psychopharmacologic agent, Curr Ther Res Clin Exp. 1963 Sep;27:463-71.
• Gallant DM, Bishop MP, Timmons E, Steele CA, Trifluperidol: a butyrophenone derivative, Am J Psychiatry. 1963 Nov;120:485-7.